Rockwell Medical Technologies, Inc. (RMTI)

[ProfitScout]

The RMTI approach to anemia treatment is a clear advancement and holds great promise for improving the lives of millions of people who suffer from this problem around the world.

From the company website:

PLATFORM TECHNOLOGY TO MANAGE IRON IN A NEW WAY

Ferric pyrophosphate citrate (FPC) is a novel complex iron salt, developed to replace iron losses in patients with anemia in an entirely new way. This unique and differentiated molecule consists of an iron atom complexed to one pyrophosphate and two citrate anions. This formulation has been shown to allow for rapid donation of iron to transferrin, protein in the blood that binds to iron and transports it through the body, including to the bone marrow. This mechanism uses the body’s own means to transport iron safely to tissues that need iron (i.e. red blood cells and muscle).

Read more here:
https://www.rockwellmed.com/our-technology/technology-platform/